Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- David Goldston, PhD
Duke University
Principal Investigator - Joan R Asarnow, PhD
University of California, Los Angeles
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ronald Reagan Medical Center
Los Angeles, California, United States
Recruiting - Olive View Ucla Education and Research Center
Sylmar, California, United States
Recruiting - Duke University
Durham, North Carolina, United States
Recruiting - Brown University
Providence, Rhode Island, United States
Recruiting - University of Utah
Salt Lake City, Utah, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Oct 2022
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 31 Dec 2025
- Registered enrollment
- 1,600
- Registry id
- NCT05304065
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.